nuvalore provides phase-appropriate analytics from early development through commercialization. Early development focuses on product characterization, CQA identification, method development, early stability, and conjugation characterization. During clinical development, the team executes stability studies, method qualification, comparability assessments, process monitoring, and characterization of development batches. For commercial readiness, nuvalore performs method validation and transfer, GMP QC testing and release support, and ongoing stability programs.